- Home
- EDIT vs SD Comparison
EDIT vs SD Comparison
Compare EDIT & SD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EDIT | SD |
|---|---|---|
| Founded | 2013 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.8M | 502.8M |
| IPO Year | 2016 | 2006 |
Fundamental Metrics
Financial Performance| Metric | EDIT | SD |
|---|---|---|
| Price | $2.62 | $13.81 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 5 | 1 |
| Target Price | $5.30 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 2.4M | 293.8K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.07% |
| EPS Growth | ★ 37.50 | 12.43 |
| EPS | N/A | ★ 0.50 |
| Revenue | ★ $31,937,000.00 | N/A |
| Revenue This Year | N/A | $12.65 |
| Revenue Next Year | N/A | $1.75 |
| P/E Ratio | ★ N/A | $28.38 |
| Revenue Growth | ★ 132.64 | N/A |
| 52 Week Low | $1.66 | $9.89 |
| 52 Week High | $4.54 | $18.45 |
Technical Indicators
Market Signals| Indicator | EDIT | SD |
|---|---|---|
| Relative Strength Index (RSI) | 37.19 | 48.76 |
| Support Level | $2.36 | $13.26 |
| Resistance Level | $2.73 | $13.99 |
| Average True Range (ATR) | 0.21 | 0.31 |
| MACD | -0.08 | 0.10 |
| Stochastic Oscillator | 2.06 | 54.70 |
Price Performance
Historical ComparisonAbout EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.
About SD SandRidge Energy Inc.
SandRidge Energy Inc is a United States-based oil and natural gas company. It is engaged in the exploration, development, and production of crude oil, natural gas, and Natural gas liquids. Business activities of the group include Exploration and Production, Drilling and Oil Field Services, and Midstream Gas Services. The company's primary areas of operation are the Mid-Continent in Oklahoma and Kansas.